Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jul. 01, 2017	Jul. 02, 2016
Cash flows from operating activities:
Net income	$ 17,726	$ 36,654
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	144,104	141,787
Loss/(gain) on disposal of property, plant, equipment and other assets	(358)	827
Gain on insurance proceeds from insurance settlements	0	(356)
Deferred taxes	(11,205)	(1,812)
Increase/(decrease) in long-term pension liability	1,362	(1,596)
Stock-based compensation expense	11,003	5,067
Write-off deferred loan costs	340	57
Deferred loan cost amortization	4,366	5,600
Equity in net income of unconsolidated subsidiaries	(8,966)	(19,495)
Distributions of earnings from unconsolidated subsidiaries	25,806	25,994
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	17,705	(20,081)
Income taxes refundable/payable	12,857	1,559
Inventories and prepaid expenses	(21,952)	(19,501)
Accounts payable and accrued expenses	16,594	30,989
Other	(11,834)	(17,460)
Net cash provided by operating activities	197,548	168,233
Cash flows from investing activities:
Capital expenditures	(127,824)	(109,406)
Acquisitions, net of cash acquired	(12,369)	(8,511)
Investment in unconsolidated subsidiary	(2,250)	0
Gross proceeds from disposal of property, plant and equipment and other assets	3,603	2,404
Proceeds from insurance settlement	3,301	1,537
Payments related to routes and other intangibles	(4,635)	0
Net cash used by investing activities	(140,174)	(113,976)
Cash flows from financing activities:
Proceeds from long-term debt	16,405	17,277
Payments on long-term debt	(67,974)	(59,255)
Borrowings from revolving credit facility	80,000	41,000
Payments on revolving credit facility	(80,327)	(47,207)
Net cash overdraft financing	(1,077)	0
Deferred loan costs	(1,177)	0
Issuance of common stock	22	143
Repurchase of common stock	0	(5,000)
Minimum withholding taxes paid on stock awards	(2,091)	(1,812)
Excess tax benefits from stock-based compensation	0	(413)
Distributions to noncontrolling interests	(2,135)	0
Net cash used by financing activities	(58,354)	(55,267)
Effect of exchange rate changes on cash	11,233	1,941
Net increase in cash and cash equivalents	10,253	931
Cash and cash equivalents at beginning of period	114,564	156,884
Cash and cash equivalents at end of period	124,817	157,815
Supplemental disclosure of cash flow information:
Accrued capital expenditures	(5,445)	(3,684)
Cash paid during the period for:
Interest, net of capitalized interest	38,688	41,813
Income taxes, net of refunds	7,986	11,799
Debt issued for assets	0	10
Contribution of assets to unconsolidated subsidiary	$ 0	$ 2,674